Glaukos GKOS
NYSE GKOS
$247.18 +11.07 (+4.69%)
At close: Nov 11, 2026 · 4:00 PM EST

Glaukos (GKOS) Gains (Losses) on Sale of Assets & Investments (2015 - 2016)

Updated

Glaukos (GKOS) reported Gains (Losses) on Sale of Assets & Investments of -$25.7 million for Q1 2016.

Analysis

Glaukos (GKOS) Gains (Losses) on Sale of Assets & Investments (2015 - 2016) Analysis & Trends

Over the twelve months ended Mar 31, 2016, Glaukos' Gains (Losses) on Sale of Assets & Investments came in at -$51.39 million; for FY2015, it was -$25.69 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn -
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn -
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn -
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn -
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn -
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 13.00 Mn
10 Glaukos 13.97 Bn 13.50 Bn 179.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 -25.70 Mn
Jun 30, 2015 -25.69 Mn
API Access

Glaukos Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=GKOS&period=max&api_key=YOUR_API_KEY